| View |
|
DRP-10276-05
|
Febuxostat
|
Goutfree 80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 March 2022
|
06 September 2026
|
| View |
|
DRP-4532-02
|
Paracetamol
|
Anagic600
|
600 mg
|
Tablet
|
Analgesic/Antipyretic (Anilide)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
08 July 2023
|
23 July 2028
|
| View |
|
DRP-6810-10
|
Co-Amoxiclav
|
QUALICLAV
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Uni Medicolabs, Inc
|
India
|
CLIDP Conversion
|
25 August 2022
|
26 August 2026
|
| View |
|
DRP-8637-10
|
Butamirate citrate
|
Kotamir
|
50 mg
|
Sustained-Release Tablet
|
Antitussives
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 April 2022
|
20 January 2025
|
| View |
|
DRP-4328-12
|
Ascorbic Acid
|
Glee-C
|
500 mg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
13 March 2023
|
25 March 2028
|
| View |
|
DRP-12598-01
|
Palonosetron (as hydrochloride)
|
Blissetron
|
50 mcg/mL (250 mcg/mL)
|
Solution for Injection (IV)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Antagonist]
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
20 October 2022
|
12 September 2027
|
| View |
|
DRP-8913-02
|
Valsartan + Amlodipine (as besilate)
|
Valsar Plus 160 / 10
|
160 mg/10 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Calcium Channel Blocker (CCB)
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
20 August 2024
|
24 June 2030
|
| View |
|
DRP-9350-05
|
Salbutamol (as sulfate)
|
Saltracit
|
100 mcg per actuation
|
Suspension Metered Dose Inhaler
|
Selective Beta-2-adrenoreceptor Agonist
|
Beximco Pharmaceuticals Ltd.
|
Bangladesh
|
CLIDP Conversion
|
07 April 2022
|
04 December 2025
|
| View |
|
DRP-8708-01
|
Esomeprazole
|
TGZol
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Gracure Pharmaceutical Ltd.
|
India
|
CLIDP Conversion
|
16 February 2022
|
07 February 2025
|
| View |
|
DRP-6528-06
|
Meropenem (as Trihydrate)
|
Meropin 500
|
500 mg
|
Powder for Solution for Injection (IV)
|
Antibacterial (Carbapenem)
|
Brooks Steriscience Limited
|
India
|
CLIDP Conversion
|
07 April 2022
|
12 February 2026
|
| View |
|
DRP-11154-05
|
Nicardipine Hydrochloride
|
Cardinova
|
1 mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
22 July 2022
|
11 February 2027
|
| View |
|
DRP-10929-11
|
Norepinephrine (As Bitartrate)
|
Noriden
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
11 July 2022
|
31 January 2027
|
| View |
|
DRP-10929-13
|
Norepinephrine (As Bitartrate)
|
Novaphrine
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
21 July 2022
|
31 January 2027
|
| View |
|
DRP-3369-14
|
Paracetamol
|
None
|
250 mg / 5 mL
|
Oral Suspension (Orange Flavor)
|
Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 August 2022
|
12 July 2026
|
| View |
|
DRP-12290-01
|
Sitagliptin (as phosphate)
|
Philsitz-50
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
30 August 2022
|
08 July 2027
|
| View |
|
DRP-5310-06
|
Cyclophosphamide
|
Cyphocare
|
1 g
|
Powder for Injection (IV)
|
Antineoplastic (Cell Cycle-Nonspecific Agent)
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
22 February 2024
|
28 May 2029
|
| View |
|
DRP-2448-01
|
Ofloxacin
|
None
|
3 mg/mL (0.3% w/v)
|
Otic Solution
|
Antibacterial (Fluoroquinolone)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
30 August 2022
|
14 May 2025
|
| View |
|
DRP-5107-02
|
Hydrocortisone (as sodium succinate)
|
Corticare
|
100 mg
|
Powder for Injection (IM/IV)
|
Cortecosteroid
|
Amson Vaccines & Pharma (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
19 October 2022
|
24 May 2026
|
| View |
|
DRP-12339-01
|
Olmesartan medoxomil
|
Olmephil 20
|
20 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker (ARB)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
31 August 2022
|
20 July 2027
|
| View |
|
DRP-11060-02
|
Salbutamol (as Sulfate)
|
Salumed
|
2.5 mg/2.5 mL
|
Solution for Nebulization
|
Selective beta-2 adrenergic agonist
|
Legency Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 April 2022
|
21 January 2027
|